Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: Evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML

Bone Marrow Transplantation

Volumn 33, Issue 1, 2004, Pages 113-115

  Pulsipher, M A ^a   Adams, R H ^b   Asch, J ^a   Petersen, F B ^a  

^a Intermountain Blood and Marrow Transplant Program   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Allogeneic stem cell transplantation; Donor lymphocyte infusion (DLI); Graft versus leukemia (GVL); Interferon alpha; Juvenile myleomonocytic leukemia (JMML)

Indexed keywords

ALPHA INTERFERON; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; FLUDARABINE; METHOTREXATE; THYMOCYTE ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CHILD; CHILD CARE; CHIMERA; CHROMOSOME ABERRATION; DOSE RESPONSE; EVIDENCE BASED MEDICINE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IMMUNOMODULATION; JUVENILE MYELOMONOCYTIC LEUKEMIA; LYMPHOCYTE TRANSFUSION; MONOSOMY 7; PRIORITY JOURNAL; PUBLICATION; SKIN MANIFESTATION; SPLENECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 7; DISEASE-FREE SURVIVAL; GRAFT VS LEUKEMIA EFFECT; HUMANS; INFANT; INTERFERON-ALPHA; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LYMPHOCYTE TRANSFUSION; RECURRENCE; REMISSION INDUCTION; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0742324362     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704287     Document Type: Article

References (10)

1. Niemeyer CM, Arico M, Basso G et al. Chronic myelomonocytic leukaemia in childhood. A retrospective analysis of 110 cases. Blood 1997; 89: 3534-3543.
2. Smith FO, King R, Neson G et al. Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. Br J Haematol 2002; 116: 716-724.
3. Manabe A, Okamura J, Yumura-Yagi K et al. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the international JMML working group. Leukemia 2002; 16: 645-649.
4. Matthes-Martin S, Mann G, Peters C et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single center experience and review of the literature. Bone Marrow Transplant 2000; 26: 377-382.
5. Worth A, Rao K, Webb D et al. Successful treatment of juvenile myelomonocytic leukaemia relapsing post stem cell transplant using donor lymphocyte infusion. Blood 2003; 101: 1713-1714.
6. Ohta H, Kawai M, Sawada A et al. Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha. Bone Marrow Transplant 2000; 26: 681-683.
7. Grigg A, Kanna K, Schwarer AP et al. Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation. Intern Med J 2001; 31: 15-22.
8. Higano CS, Chielens D, Rasking W et al. Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation. Blood 1997; 90: 2549-2554.
9. Steegman JL, Casado LF, Toma JF et al. Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 23: 483-488.
10. Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor lymphocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-1268.